Table 3

Univariate analysis of the risk of cognitive decline

GroupingCognitive declineP value
NoYes
Treatment,
n (%)
Butylphthalide258 (83.5)51 (16.5)0.022
Control225 (76.0)71 (24.0)
Gender, n (%)Men350 (82.2)76 (17.8)0.028
Women133 (74.3)46 (25.7)
Age, mean (SD), y61.19 (8.59)64.19 (7.63)< 0.001
Age group, n (%)< 60 years200 (84.7)36 (15.3)0.016
≥ 60 years283 (76.7)86 (23.3)
Education years, mean (SD), y7.42 (3.40)6.17 (3.47)< 0.001
Educational level, n (%)0 years23 (65.7)12 (34.3)0.007
1~6 years178 (76.1)56 (23.9)
> 6 years282 (83.9)54 (16.1)
Smoking status, n (%)Never176 (74.9)59 (25.1)0.013
Former198 (85.7)33 (14.3)
Current109 (78.4)30 (21.6)
Alcohol use, n (%)Never202 (75.1)67 (24.9)0.034
Former197 (83.8)38 (16.2)
Current84 (83.2)17 (16.8)
CHD, n (%)No429 (80.3)105 (19.7)0.398
Yes54 (76.1)17 (23.9)
BMI, mean (SD), kg/m226.85 (3.50)26.41 (3.24)0.216
BMI category, n (%)Thin2 (100.0)0 (0.0)0.476
Normal99 (80.5)24 (19.5)
Overweight216 (77.4)63 (22.6)
Obese166 (82.6)35 (17.4)
SBP, mean (SD), mmHg152.33 (20.72)155.06 (18.82)0.205
FBG, mean (SD), mmol/L6.78 (2.18)6.98 (2.38)0.381
TC, mean (SD), mmol/L4.37 (1.09)4.45 (1.07)0.464
TG, mean (SD), mmol/L1.60 (1.20)1.51 (1.06)0.439
HDL-C, mean (SD), mmol/L1.21 (0.28)1.27 (0.29)0.028
  • CHD, coronary heart disease; FBG, fasting blood glucose; HDL-C, high-density lipoprotein cholesterol; SBP, systolic blood pressure; TC, total cholesterol; TG, triglyceride .